18 F-fluorodeoxyglucose positron emission tomography-computed tomography as a screening tool for second primary cancers in cancer patients

Yang Liu; Jie Ma; Yingxin Liu

doi:10.18632/oncotarget.21444

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

¹⁸F-fluorodeoxyglucose positron emission tomography-computed tomography as a screening tool for second primary cancers in cancer patients

Yang Liu, Jie Ma and Yingxin Liu _

PDF | HTML | How to cite

Oncotarget. 2017; 8:92555-92560. https://doi.org/10.18632/oncotarget.21444

Metrics: PDF 1128 views | HTML 1563 views | ?

Abstract

Yang Liu1,*, Jie Ma2,* and Yingxin Liu1

1Department of Radiation Oncology, Cancer Hospital of Guangxi Medical University, Nanning, People’s Republic of China

2Department of Radiology, Cancer Hospital of Guangxi Medical University, Nanning, People’s Republic of China

*The co-first authors

Correspondence to:

Yingxin Liu, email: [email protected]

Keywords: second primary cancers, PET-CT, staging

Received: August 03, 2017 Accepted: August 18, 2017 Published: September 30, 2017

ABSTRACT

Background: We performed a meta-analysis to evaluate the value of ¹⁸F-fluorodeoxyglucose positron emission tomography-computed tomography (¹⁸FDG PET-CT) for the detection of second primary cancers in cancer patients.

Results: This present study analyzed a total of 6 selected studies (1374 patients). The sensitivity and specificity of PET-CT were 0.84 (95% confidence interval [CI] = 0.66 to 0.93), and 0.98 (95% CI = 0.97 to 0.98). Area under the curve was 0.98 (95% CI = 0.96 to 0.99).

Methods: Studies were systematically searched for relevant PET-CT original articles in the MEDLINE and EMBASE databases. We calculated the pooled sensitivity, specificity, and likelihood ratios for ¹⁸FDG PET-CT. We also constructed the summary receiver-operating characteristic curve for ¹⁸FDG PET-CT.

Conclusions: ¹⁸FDG PET-CT has high sensitivity and specificity for the detection of second primary cancers in cancer patients.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 21444

Publication Alerts

Research Papers:

18F-fluorodeoxyglucose positron emission tomography-computed tomography as a screening tool for second primary cancers in cancer patients

Abstract

¹⁸F-fluorodeoxyglucose positron emission tomography-computed tomography as a screening tool for second primary cancers in cancer patients